Hamilton Beach Brands Holding Company (HBB) Bundle
You're looking at Hamilton Beach Brands Holding Company (HBB) and seeing a classic consumer discretionary story complicated by trade policy-it's a mixed bag that demands a closer look than a simple price-to-earnings multiple allows. The company's financial health in 2025 shows real strain, particularly in the third quarter where revenue dropped 15.2% to just $132.8 million, translating to net income of only $1.7 million, or $0.12 per diluted share. This isn't just a soft consumer market; the margin pressure is acute, with the Q3 gross margin shrinking to 21.1% after a temporary 125% tariff rate on Chinese imports created a massive 370 basis point drag. That tariff risk is defintely a near-term headwind. Plus, the nine-month cash flow from operations flipped hard, moving from providing $35.2 million in 2024 to using $14.6 million in 2025, which shows inventory and accounts payable management is getting tougher. Still, with a consensus Wall Street 'Hold' rating, but an aggressive average 2025 price target forecast of $36.46, the market is clearly wrestling with HBB's true value.
Revenue Analysis
You need a clear picture of where Hamilton Beach Brands Holding Company (HBB) is making its money, and the 2025 data shows a mixed bag: strong growth in niche areas but a contraction in the core business. Through the first nine months of 2025, total revenue stood at $393.9 million, a decline of 10.7% compared to the same period in 2024, largely driven by macroeconomic headwinds. Still, the underlying segment performance tells a more nuanced story about where the company is building future value.
The primary revenue streams for Hamilton Beach Brands Holding Company are segmented into two main areas: Home and Commercial Products and Health. The company is primarily known for its small electric household appliances-think blenders, coffee makers, and toasters-sold under brands like Hamilton Beach and Proctor Silex in the U.S. and internationally. Plus, they have a solid Commercial business supplying restaurants and hotels with high-volume blenders and equipment.
The newer, high-growth segment is Health, primarily through the acquisition of HealthBeacon, which provides connected devices and software for managing medications. This segment, while small, is defintely a key focus for margin expansion. Here's the quick math on the Q3 2025 split:
- Home and Commercial Products: $130.9 million in Q3 2025.
- Health (HealthBeacon): $1.9 million in Q3 2025.
The year-over-year revenue trend for 2025 has been volatile. After starting the year on a positive note, with Q1 2025 revenue growing 4.0% to $133.4 million, the subsequent quarters faced significant pressure. Q2 2025 saw an 18.2% decline to $127.8 million, and Q3 2025 dropped 15.2% to $132.8 million. This sharp reversal pushed the trailing twelve months (TTM) revenue, as of September 30, 2025, to $607.43 million, reflecting a TTM year-over-year decline of 6.24%.
What this estimate hides is the impact of significant changes in the core U.S. Consumer business. The revenue decline in the second and third quarters was primarily driven by lower volumes, as retailers paused buying to assess inventory levels and react to new tariffs implemented in April 2025. This tariff-related disruption created an immediate headwind for the Home and Commercial segment, whose Q3 2025 revenue fell to $130.9 million from $155.5 million in Q3 2024.
To be fair, the company's strategic shift is showing promise in the smaller segments. The higher-margin Commercial and Health businesses grew, partially offsetting the consumer slump. For instance, the Health (HealthBeacon) segment's Q3 2025 revenue of $1.9 million was a solid increase from $1.1 million in the prior year period. This shift in customer mix, favoring higher-margin segments, is a critical factor to watch as you look deeper into profitability. For more on who is buying into this strategy, you should check out Exploring Hamilton Beach Brands Holding Company (HBB) Investor Profile: Who's Buying and Why?
| Metric | Q3 2025 Value | YoY Change | Notes |
|---|---|---|---|
| Total Quarterly Revenue | $132.8 million | -15.2% | Driven by U.S. Consumer volume decline |
| YTD Revenue (9M 2025) | $393.9 million | -10.7% | Compared to $441.2M in 9M 2024 |
| Home and Commercial Products Revenue | $130.9 million | N/A (Primary Driver of Decline) | Core appliance business |
| Health (HealthBeacon) Revenue | $1.9 million | +72.7% (vs $1.1M Q3 2024) | High-growth, higher-margin segment |
Profitability Metrics
When you look at Hamilton Beach Brands Holding Company (HBB)'s profitability in 2025, the picture is one of resilience in a challenging, tariff-hit environment. The core takeaway is that while the third quarter margins were severely compressed by a one-time tariff spike, the year-to-date performance shows better underlying operational efficiency.
For the third quarter of 2025 (Q3 2025), Hamilton Beach Brands Holding Company reported revenue of $132.8 million, but its margins were notably thin. Here's the quick math on the key profitability ratios for Q3 2025:
- Gross Profit Margin: The margin was 21.1%, which is a significant drop from the prior year's period.
- Operating Profit Margin: With an operating profit of $2.9 million, the operating margin was a narrow 2.18%.
- Net Profit Margin: Net income was just $1.7 million, resulting in a net profit margin of only 1.28%.
This compression was not a sign of fundamental business failure, but a direct, one-time hit. Management noted that the Q3 2025 gross margin included a 370 basis point impact, mostly from the flow-through of a temporary 125% tariff rate on Chinese imports. If you normalize for that tariff spike, the gross margin would have been closer to 24.8%, which is a much healthier figure and aligns better with the first half of the year.
Operational Efficiency and Margin Trends
The trend over the first three quarters of 2025 shows the volatility in cost management. You can see the sequential decline in gross margin, which is the direct result of external trade policy uncertainty:
- Q1 2025 Gross Margin: 24.6%
- Q2 2025 Gross Margin: 27.5%
- Q3 2025 Gross Margin: 21.1% (with tariff impact)
The Q2 gross margin of 27.5% was defintely a high point, driven by a strategic shift toward higher-margin segments like the Commercial and Health businesses. This indicates that the company's internal cost control and product mix strategy (operational efficiency) is strong, but it is easily overshadowed by geopolitical risks like tariffs. For the nine months ended September 30, 2025, the net income was $7.91 million on $393.92 million in sales, giving a more stable year-to-date net profit margin of approximately 2.01%.
HBB vs. Industry Averages
The small electric household appliance and consumer durables sector is known for operating with 'thin margins' due to intense competition and high input costs. In this context, HBB's underlying profitability is competitive, but its exposure to trade policy is a major risk factor. The entire consumer durables sector is exposed to geopolitical risks and high import tariffs, which are an ongoing drag on low-income consumers and supply chains.
When you compare HBB's Q3 2025 net margin of 1.28% to the general industry sentiment of 'thin margins' and 'margin erosion,' the performance is poor, but the root cause-the $5.0 million one-time tariff cost-is a clear, non-recurring item. The key is watching for margin recovery in Q4 2025 as the tariff rates on Chinese imports moderate, which the CEO expects to lead to further margin recovery.
| Metric | Q3 2025 Amount | Q3 2025 Margin |
|---|---|---|
| Revenue | $132.8 million | N/A |
| Gross Profit | $28.0 million | 21.1% |
| Operating Profit | $2.9 million | 2.18% |
| Net Income | $1.7 million | 1.28% |
To understand the investor landscape better, you should read Exploring Hamilton Beach Brands Holding Company (HBB) Investor Profile: Who's Buying and Why?
Debt vs. Equity Structure
If you're looking at Hamilton Beach Brands Holding Company (HBB), the first thing to note is their capital structure is defintely conservative. They aren't trying to turbocharge growth by loading up on debt, which is a key stability signal in the cyclical small appliance market. The company is leaning heavily on shareholder equity to finance its operations and strategic moves, like the recent push into home health technology.
As of the third quarter ending September 30, 2025, the total debt for Hamilton Beach Brands Holding Company stood firm at $50.0 million, a figure that has been remarkably consistent throughout the year. This low debt profile is a deliberate choice, helping the company navigate market volatility, especially with recent tariff spikes impacting gross margins.
Here's the quick math on their leverage, comparing the company's position to its peers:
| Metric | Hamilton Beach Brands Holding Company (Q3 2025) | Industry Average (Household Appliances) |
|---|---|---|
| Total Debt | $50.0 million | N/A |
| Total Stockholders' Equity (Q2 2025) | $164.0 million | N/A |
| Debt-to-Equity (D/E) Ratio | 0.30 | 0.72 |
A Debt-to-Equity (D/E) ratio of just 0.30 is exceptionally low for the sector. To be fair, the industry average for Household Appliances sits around 0.72, and for the broader Housewares & Specialties category, it can be as high as 1.32. This means Hamilton Beach Brands Holding Company uses less than a third as much debt as equity to fund its assets compared to the average household appliance peer. That's a lot of financial headroom.
The debt they do carry is primarily managed through a $125.0 million senior secured floating-rate revolving credit facility. While there was a $15.0 million fixed-rate Federal Home Loan Bank (FHLB) advance that matured in 2025, the overall total debt has remained stable, suggesting they've either paid it down with cash or rolled it into the revolving facility, keeping their leverage minimal. The company's net debt, which is total debt minus cash, rose slightly to $32.8 million as of September 30, 2025, up from the prior year, but this is still a very manageable figure.
The capital allocation story here isn't about debt; it's about returning capital to shareholders. The company's management is clearly prioritizing equity funding and direct returns, which is a strong sign of financial health and confidence in their cash flow generation.
- Declared a regular quarterly dividend of $0.12 per share.
- Repurchased $20.7 million in shares through Q3 2025 under the existing program.
- Approved a new $25.0 million stock repurchase program starting in January 2026.
This focus on share buybacks and dividends, coupled with a 'Hold (C)' credit rating from Weiss Ratings, tells you the market sees a stable, low-risk balance sheet. They are funding their growth and strategic diversification into the home health market not with risky debt, but with retained earnings and a commitment to shareholder value. For a deeper dive into who is buying the stock, you should check out Exploring Hamilton Beach Brands Holding Company (HBB) Investor Profile: Who's Buying and Why?.
Liquidity and Solvency
You want to know if Hamilton Beach Brands Holding Company (HBB) has the cash to cover its near-term obligations, and the quick answer is yes, but the quality of that liquidity is mixed. The company maintains a strong Current Ratio, but its Quick Ratio signals a heavy reliance on inventory, which is common for a consumer durables business.
As of a recent analysis, Hamilton Beach Brands Holding Company's Current Ratio sits at a healthy 2.15. This means for every dollar of short-term debt (current liabilities), the company has $2.15 in assets that should convert to cash within a year (current assets). That's a solid buffer. However, the Quick Ratio (or acid-test ratio), which strips out inventory-often the least liquid current asset-is only 0.86. This tells you that without selling down its inventory, the company cannot immediately cover all its current liabilities. It's a classic inventory-heavy model, so you need to keep a close eye on inventory turnover.
The company's working capital trends show a continued focus on efficiency, although the cash generated from it has slowed from previous peaks. Net working capital provided cash of $16.3 million in the first quarter of 2025, which is a significant contribution to liquidity. For perspective, this follows a period where working capital provided $14.5 million in cash for the full year 2024, down from $49.5 million in 2023, which benefited from post-pandemic inventory normalization. This suggests the easy wins from working capital improvements are mostly behind them, and future cash generation will rely more on core profitability.
Here's the quick math on the key liquidity metrics:
| Metric | Value (2025) | Interpretation |
|---|---|---|
| Current Ratio | 2.15 | Strong ability to cover short-term debt with all current assets. |
| Quick Ratio | 0.86 | Relies on inventory sales to fully cover short-term debt. |
| Cash & Equivalents (Sep 30, 2025) | $17.175 million | Immediate cash on hand. |
Looking at the cash flow statements, the operating engine is generating cash, but not enough to fund all activities. For the 2025 fiscal year, the operating cash flow is projected at $9.13 million. This is a positive, but the company's free cash flow-Operating Cash Flow minus Capital Expenditures-is projected at a negative $-23.00 million for the year. This means the cash generated from core business activities is not covering the necessary investments and capital spending.
The trends in investing and financing are also telling. For the nine months ended September 30, 2025, net cash used for investing activities decreased by $10.5 million compared to 2024, primarily because the 2024 period included the HealthBeacon acquisition. In financing, the company used $12.7 million for the first nine months of 2025, mainly for share repurchases and dividends, a slight decrease from the prior year. This capital allocation strategy, returning value to shareholders, is only sustainable with consistent, positive free cash flow, which is currently a defintely near-term risk.
The major liquidity strength is the manageable debt load. The company's total debt was $50.0 million as of March 31, 2025, but its Net Debt (Total Debt minus Cash) was only $1.7 million. This low net debt position provides significant flexibility and a strong foundation for financial maneuverability, even with the negative free cash flow forecast. You can dig deeper into the shareholder strategy here: Exploring Hamilton Beach Brands Holding Company (HBB) Investor Profile: Who's Buying and Why?
- Monitor inventory levels closely for potential write-downs.
- Watch for improvements in free cash flow in Q4 2025 earnings.
- The low net debt offers a strong balance sheet cushion.
Valuation Analysis
You're looking at Hamilton Beach Brands Holding Company (HBB) and asking the core question: is this stock a bargain, or is the low price a sign of trouble? Honestly, the valuation metrics right now suggest the market is treating HBB like a deep-value play, but with a cautious eye on the near-term economic headwinds. The numbers point to a defintely undervalued stock based on historical and peer comparisons, but the analyst consensus is still a hesitant 'Hold.'
The key to understanding HBB's valuation lies in its multiples. As of late November 2025, the stock is trading around the $14.37 mark, near its 52-week low of $12.72, having pulled back significantly from its 52-week high of $21.20. This price action reflects the 17.81% decline over the last 12 months, which is a clear market signal of reduced consumer demand and margin pressure. Still, the underlying metrics are compelling.
Here's the quick math on the core valuation ratios, using trailing twelve months (TTM) data ending September 2025:
- Price-to-Earnings (P/E) Ratio: The P/E ratio sits at approximately 6.12. This is a very low multiple for most sectors, suggesting investors are willing to pay only $6.12 for every dollar of HBB's earnings. A P/E this low often signals undervaluation or an expectation of declining future earnings.
- Price-to-Book (P/B) Ratio: The P/B is roughly 1.29. This means the stock is trading only 29% above its net asset value, which is quite modest for a company with established brands like Hamilton Beach and Proctor Silex.
- Enterprise Value-to-EBITDA (EV/EBITDA): This metric, which accounts for debt (Enterprise Value) and operating profitability (EBITDA), is around 6.78. This is a solid, low multiple, confirming the P/E's signal that the company is cheap on an operating cash flow basis.
When you look at the dividend, HBB offers a meaningful return while you wait for a potential turnaround. The company has an annualized dividend of about $0.48 per share, translating to a dividend yield of roughly 3.4%. Plus, the payout ratio is very sustainable at only about 20.4%, meaning they are only using a small portion of earnings to cover the dividend, leaving plenty of cash for operations, debt repayment, and their authorized $25.00 million share repurchase program, which itself signals management believes the stock is undervalued. That's a strong vote of confidence from the inside.
The professional consensus, however, remains cautious. Analysts currently have a consensus rating of 'Hold' on Hamilton Beach Brands Holding Company (HBB). This 'Hold' reflects the low valuation but also the persistent macroeconomic risks and limited analyst coverage. It's a classic case of low valuation meeting low growth expectations. To dive deeper into who is buying and why, you might want to read Exploring Hamilton Beach Brands Holding Company (HBB) Investor Profile: Who's Buying and Why?
Here is a summary of the key valuation figures:
| Metric | Value (Approx. Nov 2025) | Interpretation |
|---|---|---|
| Stock Price | $14.37 | Near 52-week low ($12.72) |
| P/E Ratio (TTM) | 6.12 | Suggests undervaluation |
| P/B Ratio | 1.29 | Modest premium to book value |
| EV/EBITDA (TTM) | 6.78 | Cheap on an operating cash flow basis |
| Dividend Yield | 3.4% | Attractive yield for a Consumer Durables stock |
| Analyst Consensus | Hold | Low valuation offset by near-term risk |
What this estimate hides is the potential for a quick re-rating if the consumer environment improves or if the company's cost-saving and new product initiatives, which drove a 4.0% revenue increase in Q1 2025, gain traction. The risk, of course, is that a prolonged downturn keeps the stock range-bound. Your action here is to set a clear entry point, perhaps closer to the 52-week low, and monitor the next two quarters for sustained revenue growth and margin expansion.
Risk Factors
You're looking at Hamilton Beach Brands Holding Company (HBB) and wondering what could derail the story, which is smart. The company operates in a mature, highly competitive space, so the risks are real and demand your attention, especially given the volatility we've seen in the 2025 fiscal year.
The biggest near-term headache is external and centers on geopolitical trade friction. The company's asset-light model, which relies on a global network of third-party manufacturers, primarily in China, is a double-edged sword. It keeps capital expenditures low, but it makes HBB acutely vulnerable to tariffs and supply chain shocks. This risk hit hard in the third quarter of 2025, where a temporary spike in tariff rates on Chinese imports to 125% caused a one-time incremental tariff cost of $5.0 million, which slashed the gross margin by 370 basis points to 21.1%.
- Tariffs are a direct hit to margins.
Operationally, this has translated into a sales slump. Total revenue for the third quarter of 2025 declined 15.2% to $132.8 million compared to the prior year, primarily due to lower volumes in the U.S. consumer business and reduced retailer purchasing. This is a clear sign of the intense price competition and the negotiating power of major customers like Walmart and Amazon, which makes margin preservation a constant battle.
On the financial front, we've seen a shift in working capital. For the nine months ended September 30, 2025, HBB reported $14.6 million in net cash used for operating activities, a sharp reversal from the $35.2 million provided in the same period a year ago. This led to an increase in net debt, which stood at $32.8 million as of September 30, 2025, up from $22.5 million a year earlier. Here's the quick math on the debt change:
| Metric | September 30, 2025 | September 30, 2024 |
|---|---|---|
| Total Debt | $50.0 million | $50.0 million |
| Net Debt | $32.8 million | $22.5 million |
The strategic risk is one of execution. HBB is making a high-stakes pivot into the higher-margin home health technology sector through the 2024 acquisition of HealthBeacon. This is a necessary move to diversify, but it introduces new operational and integration risks as the company navigates the complex regulatory and commercial landscape of medical technology. It's a completely different animal from selling blenders. You can learn more about the investor view on this strategic shift here: Exploring Hamilton Beach Brands Holding Company (HBB) Investor Profile: Who's Buying and Why?
Management is defintely not sitting still, however. They've been proactive with mitigation strategies. To offset cost pressures, they executed an 8% workforce reduction, which is expected to generate $10 million in annualized savings in the second half of 2025. They are also diversifying their manufacturing base, accelerating sourcing from other Asia Pacific countries to reduce their exposure to Chinese tariffs. Plus, they are using capital allocation to signal confidence, having repurchased 1,034,446 shares for $20.7 million through September 30, 2025, under the existing program.
Finance: Monitor the net debt-to-EBITDA ratio for the full 2025 fiscal year to gauge the true impact of the operating cash flow reversal.
Growth Opportunities
The core takeaway for Hamilton Beach Brands Holding Company (HBB) is that its future growth is defintely a story of strategic diversification, moving beyond the mature small appliance market into higher-margin sectors. You're looking at a company that is actively pivoting its business model, balancing the stability of its traditional brands with the high-growth potential of connected home health technology and premium products.
This isn't just a slight adjustment; it's a fundamental shift, particularly with the 2024 acquisition of HealthBeacon, a medical technology firm. This move is designed to reshape the company's long-term trajectory and margin profile, which is crucial as the core consumer business faces macroeconomic pressures.
The Health and Premium Product Pivot
The most significant growth driver is the Hamilton Beach Health subsidiary, which focuses on connected devices for at-home management of injectable medications. This is a subscription-based model, meaning recurring, high-margin revenue. In the third quarter of 2025, the Health division reached positive operating profit, with subscriptions up a strong 50%. For context, the HealthBeacon business contributed $1.5 million in revenue in the first quarter of 2025 alone.
Also, the company is pushing into the premium consumer appliance market, where it's historically been underrepresented. The launch of the premium Lotus brand, with seven products in its Professional series, is a clear signal of this intent. Plus, exclusive multiyear agreements to design and distribute specialty products like Bartesian cocktail makers and Numilk plant-based milk makers further diversify the portfolio into higher-end, niche categories.
Strategic Response to Market Headwinds and Financial Trajectory
Near-term, the biggest risk-and the clearest operational opportunity-is managing the impact of steep U.S. tariffs on imports from China, which spiked as high as 145% on some goods. This uncertainty forced management to suspend its forward-looking guidance in early 2025. But they're not sitting still. The strategic initiative to diversify sourcing is aggressive, with a goal to have approximately two-thirds of U.S. sales sourced from outside of China by the end of 2025.
This proactive cost management, including an 8% workforce reduction that generated $10 million in annualized savings, is aimed at protecting the bottom line while the sourcing shift takes effect. The competitive advantage here lies in their strong brand equity, which allows them to implement necessary price adjustments without losing significant market share.
Here's the quick math on the 2025 performance through Q3:
| Metric | Q1 2025 Result | Q3 2025 Result | 9 Months YTD 2025 |
|---|---|---|---|
| Total Revenue | $133.4 million (+4.0% YoY) | $132.8 million (-15.2% YoY) | $393.92 million |
| Diluted EPS | $0.13 | $0.12 | $0.58 |
| Gross Margin | 24.6% | 21.1% (Impacted by $5.0M tariff cost) | N/A |
The Q3 gross margin dip to 21.1% was a direct hit from a one-time incremental tariff cost of $5.0 million, which management believes they have now fully absorbed, setting the stage for margin recovery in the coming quarters. You can dive deeper into the shareholder profile and capital allocation, including the new $25 million stock repurchase program authorized for 2026-2027, by Exploring Hamilton Beach Brands Holding Company (HBB) Investor Profile: Who's Buying and Why?
The company also continues to prioritize shareholder returns, raising its quarterly cash dividend to $0.12 per share, payable on December 16, 2025. This consistent return of capital, alongside the strategic pivot, provides a clear framework for evaluating the investment.
- Focus on HealthBeacon's subscription growth rate.
- Monitor the Q4 2025 gross margin for tariff mitigation evidence.
- Track the progress of the two-thirds non-China sourcing goal.
Next Step: Portfolio Manager: Re-run your valuation models with a higher-margin profile for the Health division's long-term contribution by end of next week.

Hamilton Beach Brands Holding Company (HBB) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.